Schedule 13G ownership disclosure

Allena Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 018119107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
418,076
Percent of class
1.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-19-000660
Form type
SC 13G/A
Filer
Allena Pharmaceuticals, Inc.
CIK
CIK 1624658
Filed
Dec 09, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub